Close

GEMIN2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes one of the proteins found in the SMN complex, which consists of several gemin proteins and the protein known as the survival of motor neuron protein. The SMN complex is localized to a subnuclear compartment called gems (gemini of coiled bodies) and is required for assembly of spliceosomal snRNPs and for pre-mRNA splicing. This protein interacts directly with the survival of motor neuron protein and it is required for formation of the SMN complex. A knockout mouse targeting the mouse homolog of this gene exhibited disrupted snRNP assembly and motor neuron degeneration. [provided by RefSeq, Aug 2011]
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-LY1118 Anti-GEMIN2 (2E17) h(41BB-CD3ζ) CAR, pCDCAR1 2E17 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1119 Anti-GEMIN2 (4C11) h(41BB-CD3ζ) CAR, pCDCAR1 Human 4C11 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1120 Anti-GEMIN2 (CBLG1-2699) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse, Rat, Human CBLG1-2699 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1121 Anti-GEMIN2 (CBLG1-2700) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBLG1-2700 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1122 Anti-GEMIN2 (CBLG1-2701) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBLG1-2701 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1123 Anti-GEMIN2 (CBLG1-2702) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBLG1-2702 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY1124 Anti-GEMIN2 (CBLG1-2703) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBLG1-2703 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2758 Anti-GEMIN2(2E17) h(CD28-CD3ζ) CAR, pCDCAR1 2E17 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2759 Anti-GEMIN2(4C11) h(CD28-CD3ζ) CAR, pCDCAR1 Human 4C11 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2760 Anti-GEMIN2(CBLG1-2699) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse, Rat, Human CBLG1-2699 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2761 Anti-GEMIN2(CBLG1-2700) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBLG1-2700 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2762 Anti-GEMIN2(CBLG1-2701) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBLG1-2701 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2763 Anti-GEMIN2(CBLG1-2702) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBLG1-2702 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2764 Anti-GEMIN2(CBLG1-2703) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBLG1-2703 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.